Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CADL
CADL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CADL News
Candel Plans to Submit New Drug Application
May 16 2026
stocktwits
Candel Plans to Submit Biologics License Application
May 15 2026
stocktwits
Candel Therapeutics Reports Earnings, Stock Volatility Observed
May 14 2026
stocktwits
Candel Therapeutics Q1 Earnings Beat Expectations with Strong Cash Position
May 14 2026
seekingalpha
United Community Banks Acquires Candel Therapeutics for $2.2 Billion
May 04 2026
NASDAQ.COM
Candel Therapeutics Stock Seen as Deeply Undervalued Ahead of Key Trial Data
Apr 20 2026
stocktwits
Candel Therapeutics Shares Surge 24% on Positive Trial News
Apr 17 2026
stocktwits
Candel Therapeutics Reports Positive Mid-Stage Trial Results for CAN-2409
Mar 17 2026
seekingalpha
Candel Therapeutics Reports Q4 2025 Financial Results
Mar 12 2026
seekingalpha
Candel Therapeutics Announces Public Offering Pricing
Feb 20 2026
Benzinga
U.S. Stock Futures Rise as Market Awaits GDP Data Release
Feb 20 2026
Benzinga
Candel Therapeutics Prices $100 Million Share Offering
Feb 20 2026
NASDAQ.COM
Candel Therapeutics Prices $100M Public Offering
Feb 20 2026
seekingalpha
Candel Therapeutics Prices $100 Million Public Offering
Feb 20 2026
Newsfilter
Candel Therapeutics Prices Public Offering at $5.45 per Share
Feb 20 2026
Yahoo Finance
Candel Launches $100 Million Public Offering
Feb 20 2026
stocktwits
Show More News
